Editorial comment.
Nieder
Alan M
AM
D000283:Administration, Intravesical; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage*; D002295:Carcinoma, Transitional Cell / Q000517:prevention & control* / Q000601:surgery*; D003131:Combined Modality Therapy; D015251:Epirubicin / Q000008:administration & dosage*; D006801:Humans; D007680:Kidney Neoplasms / Q000517:prevention & control* / Q000601:surgery*; D016685:Mitomycin / Q000008:administration & dosage*; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D009392:Nephrectomy; D011182:Postoperative Care; D014513:Ureter / Q000601:surgery*; D014516:Ureteral Neoplasms / Q000517:prevention & control* / Q000601:surgery*
D000903:Antibiotics, Antineoplastic; D015251:Epirubicin; D016685:Mitomycin